Abstract
Twenty-five GH-deficient children were treated with GHRH (1-44), once daily sc for 6–24 months. At the 6th month of therapy, 40% of our patients showed a catch-up growth (responded), while the remaining 60% did not (nonre-sponders). No differences in auxological and biological variables at inclusion were found between the two groups. However, integrated GH secretion elicited by iv GHRH at inclusion was significantly (p<0.025) higher in responders than in non responded. During GHRH therapy, no significant increase in IGF 1/SmC was found in both groups. In all patients treatment was discontinued after 6–24 months, when its effect on growth rate failed. After a wash-out period of at least 6 months, patients were submitted to biosynthetic GH therapy. After 6 months of GH treatment a significant catch-up growth was found in both responder and non-responder children. Although the majority of GH-deficient children have hypothalamic rather than pituitary dysfunction, GHRH therapy is found to be less effective than GH treatment. Other methods of GHRH administration are worth investigating.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Guillemin R., Brazeau P., Bohlen P., Esch F., Ling N., Wehrenberg W. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science 218: 585, 1982.
Rivier J., Spiess J., Thorner M.O., Vale W. Characterization of growth hormone-releasing factor from a human pancreatic islet tumor. Nature 200: 276, 1982.
Schriock E.A., Lustig R.H., Rosenthal S.M., Kaplan S.L., Grumbach M.M. Effect of growth hormone (GH)-releasing hormone (GRH) on plasma GH in relation to magnitude and duration of GH deficiency in 26 children and adults with isolated GH deficiency or multiple pituitary hormone deficiencies: evidence for hypothalamic GRH deficiency. J. Clin. Endocrinol. Metab. 58: 1043, 1984.
Takano K., Hizuka N., Shizume K., Asakawa K., Miyakawa M., Hirose N., Shibasaki T., Ling N. Plasma growth hormone (GH) response to GH-re-leasing factor in normal children with short stature and patients with pituitary dwarfism. J. Clin. Edocrinol. Metab. 58: 236, 1984.
Laron Z., Bauman B. Growth hormone releasing hormone (GH-RH, GRF)—an important new clinical tool. Eur. J. Pediatr. 145: 6, 1986.
Bozzola M., Tatò L., Cisternino M., Nava C., Valtorta A., Chiesa M., Severi F., Gaburro D. Synthetic growth hormone-releasing hormone (GHRH 1-44) in the differential diagnosis between hypothalamic and pituitary GH deficiency. J. Endocrinol. Invest. 9: 503, 1986.
Low L.C.K., Wang C., Cheung P.T., Ho P., Lam. K.S.L., Young R.T.T., Yeung C.Y., Ling N. Long term pulsatile growth hormone (GH)-releasing hormone therapy in children with GH deficiency. J. Clin. Endocrinol. Metab. 66: 611, 1988.
Wit J.M., Otten B.J., Waelkens J.J.J., Oostdijk W., Krabbe J., Rochefort J.G., Van den Brande J.L. Short-term effect on growth of two doses of GRF 1-44 in children with growth hormone deficiency: com parison with growth induced by methionyl-GH ad ministration. Horm. Res. 27: 181, 1987.
Thorner M.O., Rogol A.D., Blizzard R.M., Klingensmith G.J., Najjar J., Misra R., Burr I., Chao G., Martha P., Mc Donald J., Pezzoli S., Chitwood J., Furlanetto R., Rivier J., Vale W., Smith P., Brook C. Acceleration of growth rate in growth hormone-def icient children treated with human growth hormone-releasing hormone. Pediatr. Res. 24: 145, 1988.
Ross R.J.M., Rodda C., Tsagarakis S., Davies P.S.W., Grossman A., Rees L.H., Preece M.A., Savage M.O. Treatment of growth-hormone deficiency with growth-hormone-releasing hormone. Lancet 1: 5, 1987.
Smith P.J., Brook C.G.D. The place of intravenous GHRH 1-40 studies in the therapy of growth hormone-deficient children with GHRH. Clin. Endocrinol. (Oxf.) 27: 97, 1987.
Butenandt O., Staud B. Comparison of growth hormone releasing hormone therapy and growth hormone therapy in growth hormone deficiency. Eur. J. Pediatr. 148: 393, 1989.
Thorner M.O., Reschke J., Chitwood J., Rogol A., Furlanetto R., Rivier J., Vale W., Blizzard R. Acceleration of growth in two children treated with human growth hormone-releasing factor. N. Engl. J. Med. 312: 4, 1985.
Rochiccioli P.E., Tauber M.T., Coude F.X., Arnone M., Morre M., Uboldi F., Barbeau C. Results of 1 — year growth hormone (GH)-Releasing hormone-(1-44) treatment on growth, Somatomedin-C, and 24-hour GH secretion in six children with partial GH deficiency. J. Clin. Endocrinol. Metab. 65: 268, 1987.
Hümmelink R., Rohwedder R., Sippel W.G. Nine months’ subcutaneous therapy with synthetic growth hormone releasing factor in children with short stature. Acta Pediatr. Scand. (Suppl.) 331: 48, 1987.
Vance M.L., Kaiser D.L., Rivier J., Vale W., Thorner M.O. Dual effect of growth hormone (GH)-releasing hormone infusion in normal men: somatotroph desensitization and increase in releasable GH. J. Clin. Endocrinol. Metab. 62: 591, 1986.
Seifert H., Bilezikjian L.M., Rivier J., Vale WW. GRF regulates the number of its binding sites in rat anterior pituitary cells. 67th Annual meeting of The Endocrine Society, Baltimore, M.D., 1985 (Abstract 140).
Frohman L.A., Jansson J.O. Growth hormone-releasing hormone. Endocr. Rev. 3: 223, 1986.
Katakami H., Arimura A., Frohman L.A. Growth hormone (GH)-releasing factor stimulates hypothalamic somatostatin release: an inibitory feedback effect on GH secretion. Endocrinology 118: 1872, 1986.
Vance M.L., Kaiser D.L., Evans W.S., Thorner M.O., Furlanetto R., Rivier J., Vale W., Perisutti G., Frohman L.A. Evidence for a limited growth hormone (GH)-releasing hormone (GHRH)-releasable quantity of GH: effects of 6-hour infusion of GHRH on GH secretion in normal man. J. Clin. Endocrinol. Metab. 60: 370, 1985.
Gelato M.C., Ross J.L., Malozowski S., Pesowitz O.H., Skerda M., Cassorla F., Loriaux D.L., Merriam G.R. Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short term linear growth in children with GH deficiency. J. Clin. Endocrinol. Metab. 61: 444, 1985.
Webb C.B., Vance M.L., Thorner M.O., Perisutti G., Thominet J., Rivier J., Frohman L.A. Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuation. J. Clin. Invest. 74: 96, 1984.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bozzola, M., Biscaldi, I., Cisternino, M. et al. Long term growth hormone (GH)-releasing hormone and biosynthetic GH therapy in GH-deficient children: comparison of therapeutic effectiveness. J Endocrinol Invest 13, 235–239 (1990). https://doi.org/10.1007/BF03349547
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349547